Improved efficacy by individualized combination therapy with Peg IFN-a 2a and ADV in HBeAg positive chronic hepatitis B patients.

YD, Wang; CY, Zhao; W, Wang; C, Shen; HZ, Lu; L, Zhang; WY, Yu; JY, Zhou; WZ, Yan

doi:10.5754/hge12183

Public

Improved efficacy by individualized combination therapy with Peg IFN-a 2a and ADV in HBeAg positive chronic hepatitis B patients.

Shared by NobleBlocks on May 1, 2012 • 12:00 AM UTC

Authors:

Wang YD

Zhao CY

Wang W

Abstract

<h4>Background/aims</h4>Monotherapy with pegylated interferon alpha (Peg-IFNa) or adefovir dipivoxil (ADV) to HBeAg-positive chronic hepatitis B (CHB) patients has limited effects. This study aims to evaluate therapeutic efficacy and safety of individualized combination therapy with Peg-IFNa and ADV...

Discussions